Concurrent palliative chemoradiation leads to survival and quality of life benefits in poor prognosis stage III non-small-cell lung cancer: a randomised trial by the Norwegian Lung Cancer Study Group

BACKGROUND: The palliative role of chemoradiation in the treatment of patients with locally advanced, inoperable non-small-cell lung cancer stage III and negative prognostic factors remains unresolved. METHODS: Patients not eligible for curative radiotherapy were randomised to receive either chemora...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Strøm, H H, Bremnes, R M, Sundstrøm, S H, Helbekkmo, N, Fløtten, Ø, Aasebø, U
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2013
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776981/
https://ncbi.nlm.nih.gov/pubmed/23963145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.466
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items